These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 8098699)
1. [Treatment of Raynaud's phenomenon]. Levy Y; Shoenfeld Y Harefuah; 1993 Mar; 124(5):288-91. PubMed ID: 8098699 [No Abstract] [Full Text] [Related]
2. [Treatment of Raynaud's phenomenon]. Lazareth I Ann Dermatol Venereol; 1987; 114(8):1035-8. PubMed ID: 2892456 [No Abstract] [Full Text] [Related]
3. Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon? Tagliarino H; Purdon M; Jamieson B; Hoekzema G J Fam Pract; 2005 Jun; 54(6):553-5. PubMed ID: 15939010 [No Abstract] [Full Text] [Related]
5. Raynaud's phenomenon. Gayraud M Joint Bone Spine; 2007 Jan; 74(1):e1-8. PubMed ID: 17218139 [TBL] [Abstract][Full Text] [Related]
6. [An update on the management of Raynaud's phenomenon]. Rodríguez-García JL An Med Interna; 1991 Oct; 8(10):513-20. PubMed ID: 1751694 [TBL] [Abstract][Full Text] [Related]
7. [Management of Raynaud's phenomenon]. Boccalon H; Monin A; Reggy M Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023 [No Abstract] [Full Text] [Related]
8. Treatment of Raynaud's phenomenon. García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160 [TBL] [Abstract][Full Text] [Related]
9. Recent achievements in the management of Raynaud's phenomenon. Baumhäkel M; Böhm M Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of Raynaud's phenomenon with alpha-lytic agents]. Clément DL Rev Med Liege; 1980 Oct; 35(19):650-2. PubMed ID: 6109369 [No Abstract] [Full Text] [Related]
11. Sildenafil for the treatment of Raynaud's phenomenon. Heymann WR J Am Acad Dermatol; 2006 Sep; 55(3):501-2. PubMed ID: 16908357 [No Abstract] [Full Text] [Related]
12. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up. Le Quentrec P; Lefebvre ML Angiology; 1991 Apr; 42(4):289-95. PubMed ID: 1673051 [TBL] [Abstract][Full Text] [Related]